Liposome compositions and methods for the treatment of atherosclerosis
First Claim
Patent Images
1. A pharmaceutical composition consisting essentially of:
- unilamellar liposomes having an average diameter of about 100-150 nanometers, which liposomes are not bound to a drug; and
a pharmaceutically acceptable carrier.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention provides compositions and methods for treating atherosclerosis. The compositions comprise unilamellar liposomes having an average diameter of 100-150 nanometers. Methods for treating atherosclerosis employing the compositions of the present invention are also provided.
62 Citations
22 Claims
-
1. A pharmaceutical composition consisting essentially of:
-
unilamellar liposomes having an average diameter of about 100-150 nanometers, which liposomes are not bound to a drug; and
a pharmaceutically acceptable carrier. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
- 8. A method for treating atherosclerosis in an animal comprising administering a liposome composition to the animal, which liposome composition consists essentially of unilamellar liposomes having an average diameter of about 100-150 nanometers.
-
18. A method for treating atherosclerosis in an animal comprising administering a liposome composition to the animal, which liposome composition consists essentially of unilamellar liposomes having an average diameter of about 125 nanometers.
Specification